P0565 Intravesical gemcitabine versus BCG for intermediate-/high-risk NMIBC during the BCG shortage: Safety, efficacy and cost-effectiveness

European Urology 2026

View at publisher
Authors: T. Costa, Fernandes de Carvalho, Luís Gustavo Morato de Toledo, V. Alves de Andrade, Moreira R.B.M. Bali, F. Albano, Fernandes L. Riserio, L.R. Fernandes, Giovanni Demartino
DOI: 10.1016/s0302-2838(26)01447-8
Cited by: 0

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments Urinary Bladder and Prostate Research Urinary Tract Infections Management

Publication details

Journal / source
European Urology
Volume
89
Pages
S1–S1
Publication date
13 February 2026
Language
EN